• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liquid biomarkers for fibrotic NASH - progress in a complex field.

作者信息

Schuppan Detlef, Myneni Sudharani, Surabattula Rambabu

机构信息

Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.

出版信息

J Hepatol. 2022 Jan;76(1):5-7. doi: 10.1016/j.jhep.2021.11.005. Epub 2021 Nov 17.

DOI:10.1016/j.jhep.2021.11.005
PMID:34801249
Abstract
摘要

相似文献

1
Liquid biomarkers for fibrotic NASH - progress in a complex field.用于纤维化非酒精性脂肪性肝炎的液体生物标志物——复杂领域的进展
J Hepatol. 2022 Jan;76(1):5-7. doi: 10.1016/j.jhep.2021.11.005. Epub 2021 Nov 17.
2
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统：一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
3
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.非酒精性脂肪性肝病的无创评估：临床预测规则和基于血液的生物标志物。
J Hepatol. 2018 Feb;68(2):305-315. doi: 10.1016/j.jhep.2017.11.013. Epub 2017 Dec 2.
4
MACK-3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis.MACK-3（hoMa、Ast 和 CK18 的组合）：纤维化非酒精性脂肪性肝炎有前途的新型生物标志物。
Liver Int. 2019 Jul;39(7):1315-1324. doi: 10.1111/liv.14084. Epub 2019 Mar 18.
5
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.血清槐凝集素阳性 Mac-2 结合蛋白水平预测存在纤维化非酒精性脂肪性肝炎 (NASH) 和 NASH 肝硬化。
PLoS One. 2018 Aug 30;13(8):e0202226. doi: 10.1371/journal.pone.0202226. eCollection 2018.
6
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.血清编码和非编码 RNA 作为非酒精性脂肪性肝病和纤维化严重程度的生物标志物。
Liver Int. 2019 Sep;39(9):1742-1754. doi: 10.1111/liv.14167. Epub 2019 Jun 26.
7
Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.血清免疫球蛋白A浓度是非酒精性脂肪性肝病中肝纤维化的可靠生物标志物。
World J Gastroenterol. 2014 Sep 21;20(35):12566-73. doi: 10.3748/wjg.v20.i35.12566.
8
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.非酒精性脂肪性肝病 (NAFLD) 的诊断：现状。
Curr Pharm Des. 2018;24(38):4574-4586. doi: 10.2174/1381612825666190117102111.
9
FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.FICK-3评分结合纤维化-4、胰岛素抵抗和细胞角蛋白-18预测埃及非酒精性脂肪性肝病患者的非酒精性脂肪性肝炎
Pak J Biol Sci. 2019 Jan;22(10):457-466. doi: 10.3923/pjbs.2019.457.466.
10
Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.超高场磁共振波谱在非酒精性脂肪性肝病中的应用：非酒精性脂肪性肝炎和肝纤维化能量代谢的新机制和诊断见解。
Liver Int. 2017 Oct;37(10):1544-1553. doi: 10.1111/liv.13451. Epub 2017 May 20.

引用本文的文献

1
ECM formation and degradation during fibrosis, repair, and regeneration.纤维化、修复和再生过程中的细胞外基质形成与降解。
NPJ Metab Health Dis. 2025 Jun 10;3(1):25. doi: 10.1038/s44324-025-00063-4.
2
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics.细胞外基质相关诊断与治疗的进展
J Clin Med. 2025 Mar 10;14(6):1856. doi: 10.3390/jcm14061856.
3
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care.胰岛素抵抗在2型糖尿病患者非酒精性脂肪性肝病发生发展中的作用：从实验室到患者护理
Diabetes Spectr. 2024 Winter;37(1):20-28. doi: 10.2337/dsi23-0013. Epub 2024 Feb 15.
4
High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma.基于高多重适体的血清蛋白质组学用于鉴定口腔鳞状细胞癌的候选血清生物标志物
Cancers (Basel). 2023 Mar 30;15(7):2071. doi: 10.3390/cancers15072071.
5
Non-alcoholic fatty liver disease-A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease.非酒精性脂肪性肝病——一项关于非酒精性脂肪性肝病与酒精性肝病早期炎症和纤维化生物标志物的初步研究。
Front Physiol. 2022 Dec 15;13:963513. doi: 10.3389/fphys.2022.963513. eCollection 2022.
6
The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application.肝脏纤维化的分子机制及其在应用中的潜在治疗方法。
Int J Mol Sci. 2022 Oct 20;23(20):12572. doi: 10.3390/ijms232012572.